The Journal of Immunology, Vol 156, Issue 6 2133-2142, Copyright © 1996 by American Association of Immunologists

ARTICLES

Phenotype and function of CD4+ T cells in mice lacking invariant chain

P Wong and AY Rudensky
Howard Hughes Medical Institute, Department of Immunology, University of Washington School of Medicine, Seattle 98195, USA.

Mice bearing a targeted disruption of the gene encoding the invariant chain (Ii) have provided a deeper understanding of the critical role that Ii plays in the assembly, transport, and peptide occupancy of MHC class II molecules. In this study, we have investigated the consequence of the altered class II expression in Ii-deficient (Ii zero) mice on the phenotype and function of their CD4+ T cells. As seen by others, these mice show a sharp reduction in the CD4+8- subset in the thymus and periphery. Furthermore, a large proportion of the peripheral CD4+, but not CD8+, T cells in Ii zero mice exhibit decreased surface TCR- alpha beta levels and express markers of T cell activation. Although the CD4+ T cells respond to mitogens, anti-CD3 mAbs, and alloantigens, they respond poorly to the bacterial superantigen staphylococcal enterotoxin B and do not respond to peptide and protein Ags. Analysis of reciprocal radiation bone marrow chimeras constructed using Ii zero and wild-type mice indicate that the lack of Ii in the thymus is responsible for the phenotype of the CD4+ T cells in mutant mice. These results suggest that the altered thymic peptide repertoire displayed by class II molecules in the absence of Ii has a dramatic impact on the selection of CD4+ T cells and their phenotype in the periphery.

This article has been cited by other articles:

				S. Huang, S. Gilfillan, S. Kim, B. Thompson, X. Wang, A. J. Sant, D. H. Fremont, O. Lantz, and T. H. Hansen MR1 uses an endocytic pathway to activate mucosal-associated invariant T cells J. Exp. Med., May 12, 2008; 205(5): 1201 - 1211. [Abstract] [Full Text] [PDF]

				R. J. Mellanby, C. H. Koonce, A. Monti, J. M. Phillips, A. Cooke, and E. K. Bikoff Loss of Invariant Chain Protects Nonobese Diabetic Mice against Type 1 Diabetes J. Immunol., December 1, 2006; 177(11): 7588 - 7598. [Abstract] [Full Text] [PDF]

				M. Erickson, S. Morkowski, S. Lehar, G. Gillard, C. Beers, J. Dooley, J. S. Rubin, A. Rudensky, and A. G. Farr Regulation of thymic epithelium by keratinocyte growth factor Blood, October 16, 2002; 100(9): 3269 - 3278. [Abstract] [Full Text] [PDF]

				G. Rajagopalan, M. K. Smart, C. J. Krco, and C. S. David Expression and Function of Transgenic HLA-DQ Molecules and Lymphocyte Development in Mice Lacking Invariant Chain J. Immunol., August 15, 2002; 169(4): 1774 - 1783. [Abstract] [Full Text] [PDF]

				S. M. Tompkins, J. Padilla, M. C. Dal Canto, J. P.-Y. Ting, L. Van Kaer, and S. D. Miller De Novo Central Nervous System Processing of Myelin Antigen Is Required for the Initiation of Experimental Autoimmune Encephalomyelitis J. Immunol., April 15, 2002; 168(8): 4173 - 4183. [Abstract] [Full Text] [PDF]

				I. Topilski, A. Harmelin, R. A. Flavell, Y. Levo, and I. Shachar Preferential Th1 Immune Response in Invariant Chain-Deficient Mice J. Immunol., February 15, 2002; 168(4): 1610 - 1617. [Abstract] [Full Text] [PDF]

				R. Pacholczyk, P. Kraj, and L. Ignatowicz Peptide Specificity of Thymic Selection of CD4+CD25+ T Cells J. Immunol., January 15, 2002; 168(2): 613 - 620. [Abstract] [Full Text] [PDF]

				T. V. Golovkina, Y. Agafonova, D. Kazansky, and A. Chervonsky Diverse Repertoire of the MHC Class II-Peptide Complexes Is Required for Presentation of Viral Superantigens J. Immunol., February 15, 2001; 166(4): 2244 - 2250. [Abstract] [Full Text] [PDF]

				P. Wong, A. W. Goldrath, and A. Y. Rudensky Competition for Specific Intrathymic Ligands Limits Positive Selection in a TCR Transgenic Model of CD4+ T Cell Development J. Immunol., June 15, 2000; 164(12): 6252 - 6259. [Abstract] [Full Text] [PDF]

				B. Chmielowski, P. Muranski, P. Kisielow, and L. Ignatowicz On the role of high- and low-abundance class II MHC-peptide complexes in the thymic positive selection of CD4+ T cells Int. Immunol., January 1, 2000; 12(1): 67 - 72. [Abstract] [Full Text] [PDF]

				W. C. Kieper and S. C. Jameson Homeostatic expansion and phenotypic conversion of naive T cells in response to self peptide/MHC ligands PNAS, November 9, 1999; 96(23): 13306 - 13311. [Abstract] [Full Text] [PDF]

				G. Kenty and E. K. Bikoff BALB/c Invariant Chain Mutant Mice Display Relatively Efficient Maturation of CD4+ T Cells in the Periphery and Secondary Proliferative Responses Elicited upon Peptide Challenge J. Immunol., July 1, 1999; 163(1): 232 - 241. [Abstract] [Full Text] [PDF]

				T. Nakagawa, W. Roth, P. Wong, A. Nelson, A. Farr, J. Deussing, J. A. Villadangos, H. Ploegh, C. Peters, and A. Y. Rudensky Cathepsin L: Critical Role in Ii Degradation and CD4 T Cell Selection in the Thymus Science, April 17, 1998; 280(5362): 450 - 453. [Abstract] [Full Text]

				K. Swier, D. R. Brown2, J. J. Bird, W. D. Martin, L. V. Kaer, and S. L. Reiner Cutting Edge: A Critical, Invariant Chain-Independent Role for H2-M in Antigen Presentation J. Immunol., January 15, 1998; 160(2): 540 - 544. [Abstract] [Full Text] [PDF]

				D. R. Brown, K. Swier, N. H. Moskowitz, M. F. Naujokas, R. M. Locksley, and S. L. Reiner T Helper Subset Differentiation in the Absence of Invariant Chain J. Exp. Med., January 1, 1997; 185(1): 31 - 42. [Abstract] [Full Text] [PDF]